The Department of Rheumatology and Immunology, Xiangya hospital of Central South University, Changsha, China.
The Department of Pathophysiology, School of Basic Medicine Science, Central South University, Changsha, China.
Clin Rheumatol. 2024 Jan;43(1):129-135. doi: 10.1007/s10067-023-06772-9. Epub 2023 Oct 4.
This study aimed to assess the role of synovial fluid (SF) CD4T, CD19B, follicular helper cells (Tfh), and cytokines in the pathogenesis of rheumatoid arthritis (RA).
This study enrolled 16 patients with RA and 8 patients with osteoarthritis (OA). The frequencies of the SF CD4 T, CD19 B, Tfh cells, and Tfh subsets were assessed using flow cytometry. The medical condition in patients with RA was evaluated using The Disease Activity Score 28 (DAS28), the Clinical Disease Activity Index (CDAI), and the Simplified Disease Activity Index (SDAI). Levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (anti-CCP), and rheumatoid factor (RF) were measured. The cytokines IL-4, IL-13, IL-21, and BLyS were measured by ELISA test.
The percentages of SF CD4T, CD19B, and PD-1CXCR5 Tfh in RA patients were higher than those in OA patients. And the Tfh2 was the main subset among Tfh subsets. In addition, levels of IL-21 and BLyS were higher in patients with RA compared to patients with OA. Furthermore, the treatment of TNF-α inhibitors may be associated with decreased levels of SF Tfh.
Elevated SF Tfh, B cell, and cytokines expression profiles were observed in RA patients. Tfh2 was the major subset of the Tfh, and IL-21 and BLyS were significantly enhanced. Additionally, TNF-α inhibitors reduced Tfh in SF. Therefore, Tfh, B, and Tfh2 cells could play a significant role in the progression of RA. Key Points •Tfh cells in the synovial fluid are significantly higher in RA patients and are dominated by the Tfh2 subpopulation. •Synovial fluid Tfh cells decrease in RA patients after anti-TNF-α treatment.
本研究旨在评估滑液(SF)CD4T、CD19B、滤泡辅助细胞(Tfh)和细胞因子在类风湿关节炎(RA)发病机制中的作用。
本研究纳入了 16 例 RA 患者和 8 例骨关节炎(OA)患者。采用流式细胞术评估 SF CD4T、CD19B、Tfh 细胞和 Tfh 亚群的频率。采用疾病活动评分 28(DAS28)、临床疾病活动指数(CDAI)和简化疾病活动指数(SDAI)评估 RA 患者的病情。检测 C-反应蛋白(CRP)、红细胞沉降率(ESR)、抗环瓜氨酸肽(抗-CCP)和类风湿因子(RF)的水平。通过 ELISA 试验测量细胞因子 IL-4、IL-13、IL-21 和 BLyS。
RA 患者 SF CD4T、CD19B 和 PD-1CXCR5 Tfh 的百分比高于 OA 患者。并且 Tfh2 是 Tfh 亚群中的主要亚群。此外,与 OA 患者相比,RA 患者的 IL-21 和 BLyS 水平更高。此外,TNF-α 抑制剂的治疗可能与 SF Tfh 水平降低有关。
RA 患者 SF Tfh、B 细胞和细胞因子表达谱升高。Tfh2 是 Tfh 的主要亚群,IL-21 和 BLyS 明显增强。此外,TNF-α 抑制剂减少了 SF 中的 Tfh。因此,Tfh、B 和 Tfh2 细胞可能在 RA 的进展中发挥重要作用。关键点:•RA 患者滑液中的 Tfh 细胞显著升高,且以 Tfh2 亚群为主。•RA 患者接受抗 TNF-α 治疗后,滑液 Tfh 细胞减少。